You are here

Springworks

5 Highly Anticipated FDA Decisions for Rare Diseases Coming This Year

BioSpace

Fri, 07/28/23 - 11:46 am

fibrodysplasia ossificans progressiva

Santhera Pharmaceuticals

AACR 2023 – Moderna's immunotherapeutic splash

EP Vantage

Wed, 03/22/23 - 10:03 am

Moderna Therapeutics

Relay Therapeutics

Vivace Therapeutics

ESMO 2022 movers – KRAS backfires

EP Vantage

Thu, 09/15/22 - 10:12 am

KRAS inhibitors

Relay Therapeutics

Clovis Oncology

Ayala Pharmaceuticals

Mirati Therapeutics